Aldeyra Therapeutics Inc — キャッシュフロー (NASDAQ:ALDX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -37.49 M-42.56 M-56.64 M-30.33 M-43.21 M-33.35 M -33.35 M 投資活動によるキャッシュフロー 29.02 M-7 806-29.95 M30 M-44.92 M47.74 M 47.74 M 財務活動によるキャッシュフロー 41.9 M194.5 M1.22 M-1.27 M-171.42 K1.12 M 1.12 M フリーキャッシュフロー -37.49 M-42.56 M-56.65 M-30.33 M-43.21 M-33.35 M -33.35 M

ニュース

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC、ドライアイ疾患競合の承認遅延でBausch & Lomb株の評価を維持

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

BTIGによると今年のトップヘルスケア株

Top Healthcare Stocks for This Year According to BTIG

Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know

Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?